Clinical Trials Browser

Terminated × Renal Insufficiency × Other hematologic neoplasm × Clear all

NCT02679131 2019-11-20

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Phase 1 Terminated

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms, Renal Insufficiency

NCT02360111 2019-07-24

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Phase NA Terminated

3 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Renal Insufficiency